Blood Clot Prevention
Venous thromboembolism (VTE), commonly known as a blood clot, is reported to be the leading cause of preventable hospital death. Anyone is susceptible to developing a blood clot, but certain factors can greatly increase the risk of this complication. Hospitalization for an acute medical illness or a surgery is a strong risk factor and should be considered, along with the patient’s other risks, before determining appropriate steps for helping prevent blood clot formation. Blood clot prevention requires an individualized assessment to balance each patient’s risk of bleeding and clotting. Treatment to prevent blood clots from forming may include compression stockings and medications commonly known as blood thinners.
How does UAB Medicine perform?
|Timely & Effective Measures||National Average||Alabama Average||UAB Hospital||Comparison Analysis|
|Blood clot prevention: percentage of patients who developed a blood clot while in the hospital and did not get treatment that could have prevented it||3%||4%||6%|
What is UAB Medicine doing to improve?
VTE is largely preventable through use of evidence-based guidelines.
- All patients are screened for risk factors for developing VTE.
- UAB Medicine uses clinical decision support software called VTE Advisor to provide its medical staff with access to the latest guidelines for VTE prevention and to drive best practices in preventing blood clots.
- Every VTE that occurs at UAB Medicine is closely examined, and lessons learned are shared among all staff to continually improve our quality of care.